# Tempest Therapeutics, Inc.: Form 8-K, filed Oct 30, 2026

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: 8-K
- Filed: 2026-10-30
- Accepted by EDGAR: Oct 30, 2026, 16:05 ET
- Period: 2026-10-26
- Accession: 0001213900-26-114376
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000121390026114376/ea0309738-8k_tempest.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000121390026114376/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000121390026114376/ea0309738-8k_tempest.htm

Filed Oct 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-114376. Last ingested by Listed: Nov 15, 2026, 00:20 ET. No prices; not investment advice.
